-
-
-
-
-
-
-
Spectrum Pharma (SPPI) Announces FDA Acceptance of BLA Resubmission for Eflapegrastim
-
-
-
-
-
-
-
Spectrum Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Update
-
-
-
-
-
-
-
Spectrum Pharmaceuticals Initiates Same Day Dosing Clinical Trial for ROLONTIS® (eflapegrastim)
-
-
-
-
-
-
-
Spectrum Pharmaceuticals Reports Second Quarter 2016 Financial Results and Pipeline Update
-
-
-
-
-
-
12,336 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All